Teleflex Incorporated (NYSE: TFX), a prominent global provider of medical technologies, has announced key dates for its upcoming third-quarter earnings conference call and a virtual meeting focused on its Vascular Intervention business. Investors and analysts are keenly awaiting these events as they provide insights into the company’s financial health and strategic direction.

1. Third Quarter Earnings Conference Call Scheduled

Teleflex will host its third-quarter earnings conference call on Thursday, November 6, 2025, at 8:00 a.m. Eastern Time. This call will delve into the company’s financial results for the third quarter and provide an operational update, crucial for stakeholders seeking to assess the company's performance amidst a dynamic healthcare landscape.

Participants are encouraged to pre-register for the call to receive the necessary dial-in information. Alternatively, a live audio webcast will be available on Teleflex’s official website, teleflex.com.

Replay and Access Information

For those unable to attend the live call, an audio replay will be made available starting at 11:00 a.m. Eastern Time on the same day. Investors can access the replay through the Teleflex website or by dialing in with the following numbers:

U.S. and Canada: 1-800-770-2030

All other locations: 1-609-800-9909

To access the replay, callers will need to enter the conference ID 69028.

2. Vascular Intervention Virtual Meeting

Following the earnings call, Teleflex will conduct a Vascular Intervention Virtual Meeting on November 14, 2025, at 8:00 a.m. Eastern Time. This session aims to review the recently acquired Vascular Intervention business, offering a detailed analysis of the strategic rationale behind the acquisition and the comprehensive product portfolio focused on coronary and peripheral interventions.

Registration and Participation

As with the earnings call, interested participants are invited to pre-register to receive the dial-in details. The meeting will also be accessible via a live audio webcast on Teleflex’s website.

3. About Teleflex Incorporated

Teleflex is committed to enhancing healthcare through innovative medical technologies across various therapeutic areas, including anesthesia, emergency medicine, interventional cardiology, radiology, surgical, vascular access, and urology. The company's vision is to be the most trusted partner in healthcare, driven by a diverse portfolio of well-known brands such as Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™ Rüsch™, UroLift™, and Weck™.

Through its commitment to purpose-driven innovation and world-class product development, Teleflex aims to empower the future of healthcare, improving the quality of life for patients globally.

Investors and healthcare professionals alike will be closely monitoring these upcoming events, as Teleflex continues to position itself as a leader in the medical technology sector. For more information about Teleflex and its offerings, visit their website at teleflex.com.

Original press release